SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0000950170-23-051922
Filing Date
2023-10-04
Accepted
2023-10-04 16:35:08
Documents
17

Document Format Files

Seq Description Document Type Size
1 S-1 ktra-20231004.htm   iXBRL S-1 838679
2 EX-23.1 ktra-ex23_1.htm EX-23.1 6444
3 EX-FILING FEES ktra-exfiling_fees.htm EX-FILING FEES 132030
4 GRAPHIC img139689655_0.jpg GRAPHIC 9196
5 GRAPHIC img139689655_1.jpg GRAPHIC 9196
  Complete submission text file 0000950170-23-051922.txt   1229202

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ktra-20231004_lab.xml EX-101.LAB 14007
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ktra-20231004.xsd EX-101.SCH 2896
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ktra-20231004_def.xml EX-101.DEF 11869
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ktra-20231004_pre.xml EX-101.PRE 11744
11 EXTRACTED XBRL INSTANCE DOCUMENT ktra-20231004_htm.xml XML 5629
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121 (858) 350-4364
Kintara Therapeutics, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: S-1 | Act: 33 | File No.: 333-274864 | Film No.: 231308474
SIC: 2834 Pharmaceutical Preparations